Sen. Baldwin Warns That Pharmaceutical Mergers May Increase Drug Prices, Reduce Patient Access to Essential Medications
September 17, 2019
September 17, 2019
WASHINGTON, Sept. 17 -- Sen. Tammy Baldwin, D-Wisconsin, issued the following news release:
In light of ongoing consolidation in the pharmaceutical sector, U.S. Senator Tammy Baldwin joined her Senate colleagues in calling on the Federal Trade Commission (FTC) to closely scrutinize pharmaceutical mergers that could increase prescription drug prices and reduce patient access to needed medications.
In a letter to FTC Chairman Joseph Simons led by Senator Amy Klobuchar (D- . . .
In light of ongoing consolidation in the pharmaceutical sector, U.S. Senator Tammy Baldwin joined her Senate colleagues in calling on the Federal Trade Commission (FTC) to closely scrutinize pharmaceutical mergers that could increase prescription drug prices and reduce patient access to needed medications.
In a letter to FTC Chairman Joseph Simons led by Senator Amy Klobuchar (D- . . .